Implant stability measurement developer Osstell has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Osstell Beacon guided implant treatment tool.
The Osstell Beacon helps practitioners measure implant stability and guide treatments in straightforward and complex cases. With the clearance, the tool is now available in 49 countries.
